University of Crete (UOC)
Identifications of new micromolecular ligands for the membrane receptor of androgens, oxer1 and study of their mechanism of action
Abstract
dc:descriptionThe action of androgens is mediated mainly through intracellular androgen receptors, which belong to the nuclear family of receptors. These receptors are a set of transcription fac-tors that determine key cell processes. A recent study by our team identified an alternative an-drogen receptor on the membrane of prostate cancer cells, OXER1 (5-oxo-6E, 8Z, 11Z, 14Z-eicosatetraenoic acid receptor). It is a receptor belonging to the GPCRs family, which was iso-lated and characterized approximately 18 years ago. Prostate cancer is known to be one of the most serious hormone-dependent and hormone-sensitive tumors. Prostate cancer located in the male reproductive system and most types of this cancer develop slowly. Prostate cancer is also very metastatic and can spread to other parts of the body. Epidemiological data on prostate cancer show that it is the second most common cancer. Current treatments for this cancer are not fully effective. Natural products may have a pharmacological effect and a therapeutic bene-fit in the treatment of diseases such as prostate cancer. Compounds from nature can often be used as a starting point in the process of discovering new drugs. Many prostate cancer therapies aim to inhibit androgen receptor signaling because the role of these receptors in prostate cancer is extremely important. Also, the arachidonic acid signaling pathway plays a key role in carcin-ogenesis and for this reason many natural products have been tested as inhibitors in the signal-ing and metabolism pathways of arachidonic acid and its derivatives. Membrane androgen re-ceptors (mARs) are involved in the activation of various kinases and lead to processes that af-fect the growth and metastasis of cancer cells. Finding natural products as regulators of the ac-tion of membrane androgen receptors may be the key to inhibit carcinogenic processes. The research needs for a better understanding of the mechanism of action of androgens and finding new anti-cancer therapeutic targets and / or substances is extremely high. The aim of the disser-tation was to identify micromolecular compounds that will bind to the membrane receptor of androgens, OXER1 and will have a competitive effect such as testosterone, since this receptor induces the survival of cancer cells, and possibly explore them as anticancer agents. In particu-lar, OXER1 receptor is an oxo-lipid receptor that defines important functions in conditions such as inflammatory reactions and cancer. Our research team has shown that the OXER1 re-ceptor mediates the rapid effects of androgens, as testosterone binds to it and competes with the actions of its lipid ligand (5-oxo-ETE). The OXER1 receptor is involved in allergic responses that include eosinophils and basophils. In particular, it mediates the effects of 5-oxo-ETE on eosinophil chemotaxis, actin polymerization and L-selectin elimination. It is also involved in the proliferation and development of prostate, breast, kidney and ovarian cancers. OXER1 re-ceptor function has been linked to the inhibition of cyclic 3', 5'-adenosine monophosphoric acid (cAMP), because it binds to a Gαi protein, while at the same time leading to an increase in in-tracellular calcium. In addition, activation of the OXER1 receptor induces phosphorylation of various kinases such as PI3K, Akt and ERK1/2. To achieve this study, the following approach was followed, starting with the modeling of the interaction of OXER1 receptor with testos-terone and 5-oxo-ETE. Due to the large number of natural products studied, an algorithm was designed and developed, allowing the fast and accurate classification of the examined chemical molecules. Next, using the advanced bioinformatics tool, OXER1 competitors were identified. The tool was also used to study the interaction of other receptors / proteins. The selected mole-cules were analyzed by a wide range of bioinformatics tools. In vitro verification of the com-petitive properties of the selected compounds was performed in different cellular activities. The identified natural compounds, through bioinformatics methods, were tested in a number of cellular activities, related to the Gα and Gβγ activities of OXER1, such as cAMP, actin polymer-ization and their effect on calcium ion flow. In conclusion, the achievements of present thesis work are: First, a bioinformatic tool for the fast and accurate testing of different chemical compounds for their ability to act via OXER1. A tool that can be also used to study the interac-tion of other receptors / proteins (we present three different applications that verify its useful-ness). Second, nine compounds as antagonists of OXER1 with the best one verified in vitro, and finally more data on the signaling pathways triggered by testosterone via OXER1. All these support testosterone actions at the membrane level, via OXER1, and provide new tools and agents for possible novel therapeutic approaches in cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Panagiotopoulos, Athanasios
- Παναγιωτόπουλος, Αθανάσιος
Subjects
dc:subject × 22- OXER1
- 5-oxo-ETE
- Τεστοστερόνη
- Ανδρογόνο
- Εικοσανοειδή
- Μεμβρανικός υποδοχέας
- Ανδρογονικός υποδοχέας
- Καρκίνος του προστάτη
- Φυσικά προϊόντα
- Testosterone
- Androgen
- Eicosanoids
- Membrane receptor
- Androgen receptor
- Prostate cancer
- Natural products
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Φαρμακευτική χημεία
- Basic Medicine
- Medical and Health Sciences
- Medicinal chemistry
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49691